These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 27524179)

  • 1. Hybrid Antibiotic Overcomes Resistance in P. aeruginosa by Enhancing Outer Membrane Penetration and Reducing Efflux.
    Gorityala BK; Guchhait G; Goswami S; Fernando DM; Kumar A; Zhanel GG; Schweizer F
    J Med Chem; 2016 Sep; 59(18):8441-55. PubMed ID: 27524179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterodimeric Rifampicin-Tobramycin conjugates break intrinsic resistance of Pseudomonas aeruginosa to doxycycline and chloramphenicol in vitro and in a Galleria mellonella in vivo model.
    Idowu T; Arthur G; Zhanel GG; Schweizer F
    Eur J Med Chem; 2019 Jul; 174():16-32. PubMed ID: 31022550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvants Based on Hybrid Antibiotics Overcome Resistance in Pseudomonas aeruginosa and Enhance Fluoroquinolone Efficacy.
    Gorityala BK; Guchhait G; Fernando DM; Deo S; McKenna SA; Zhanel GG; Kumar A; Schweizer F
    Angew Chem Int Ed Engl; 2016 Jan; 55(2):555-9. PubMed ID: 26610184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amphiphilic Tobramycin-Lysine Conjugates Sensitize Multidrug Resistant Gram-Negative Bacteria to Rifampicin and Minocycline.
    Lyu Y; Yang X; Goswami S; Gorityala BK; Idowu T; Domalaon R; Zhanel GG; Shan A; Schweizer F
    J Med Chem; 2017 May; 60(9):3684-3702. PubMed ID: 28409644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amphiphilic nebramine-based hybrids Rescue legacy antibiotics from intrinsic resistance in multidrug-resistant Gram-negative bacilli.
    Yang X; Ammeter D; Idowu T; Domalaon R; Brizuela M; Okunnu O; Bi L; Guerrero YA; Zhanel GG; Kumar A; Schweizer F
    Eur J Med Chem; 2019 Aug; 175():187-200. PubMed ID: 31078866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chimeric Tobramycin-Based Adjuvant TOB-TOB-CIP Potentiates Fluoroquinolone and β-Lactam Antibiotics against Multidrug-Resistant
    Dhiman S; Ramirez D; Li Y; Kumar A; Arthur G; Schweizer F
    ACS Infect Dis; 2023 Apr; 9(4):864-885. PubMed ID: 36917096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of an efflux pump inhibitor to determine the prevalence of efflux pump-mediated fluoroquinolone resistance and multidrug resistance in Pseudomonas aeruginosa.
    Kriengkauykiat J; Porter E; Lomovskaya O; Wong-Beringer A
    Antimicrob Agents Chemother; 2005 Feb; 49(2):565-70. PubMed ID: 15673734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced efficacy of putative efflux pump inhibitor/antibiotic combination treatments versus MDR strains of Pseudomonas aeruginosa in a Galleria mellonella in vivo infection model.
    Adamson DH; Krikstopaityte V; Coote PJ
    J Antimicrob Chemother; 2015 Aug; 70(8):2271-8. PubMed ID: 25921513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of antibiotic efficacy against infections caused by planktonic or biofilm cultures of Pseudomonas aeruginosa and Klebsiella pneumoniae in Galleria mellonella.
    Benthall G; Touzel RE; Hind CK; Titball RW; Sutton JM; Thomas RJ; Wand ME
    Int J Antimicrob Agents; 2015 Nov; 46(5):538-45. PubMed ID: 26364845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment of extensively drug-resistant Pseudomonas aeruginosa osteomyelitis using a colistin- and tobramycin-impregnated PMMA spacer.
    Krajewski J; Bode-Böger SM; Tröger U; Martens-Lobenhoffer J; Mulrooney T; Mittelstädt H; Russlies M; Kirchner R; Knobloch JK
    Int J Antimicrob Agents; 2014 Oct; 44(4):363-6. PubMed ID: 25182711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Steroidal alkaloids and conessine from the medicinal plant Holarrhena antidysenterica restore antibiotic efficacy in a Galleria mellonella model of multidrug-resistant Pseudomonas aeruginosa infection.
    Siriyong T; Voravuthikunchai SP; Coote PJ
    BMC Complement Altern Med; 2018 Oct; 18(1):285. PubMed ID: 30340578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial efficacy of tobramycin polymeric nanoparticles for Pseudomonas aeruginosa infections in cystic fibrosis: formulation, characterisation and functionalisation with dornase alfa (DNase).
    Deacon J; Abdelghany SM; Quinn DJ; Schmid D; Megaw J; Donnelly RF; Jones DS; Kissenpfennig A; Elborn JS; Gilmore BF; Taggart CC; Scott CJ
    J Control Release; 2015 Jan; 198():55-61. PubMed ID: 25481442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
    Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
    Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aminoglycoside Concentrations Required for Synergy with Carbapenems against Pseudomonas aeruginosa Determined via Mechanistic Studies and Modeling.
    Yadav R; Bulitta JB; Schneider EK; Shin BS; Velkov T; Nation RL; Landersdorfer CB
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28893782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymyxin B
    Domalaon R; Yang X; Lyu Y; Zhanel GG; Schweizer F
    ACS Infect Dis; 2017 Dec; 3(12):941-954. PubMed ID: 29045123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A deletion mutation in nfxB of in vitro-induced moxifloxacin-resistant Pseudomonas aeruginosa confers multidrug resistance.
    Thai VC; Pham HV; Nguyen DNM; Lambert P; Nguyen TTH
    Acta Microbiol Immunol Hung; 2017 Sep; 64(3):245-253. PubMed ID: 28560883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro antibacterial activity of rifampicin in combination with imipenem, meropenem and doripenem against multidrug-resistant clinical isolates of Pseudomonas aeruginosa.
    Hu YF; Liu CP; Wang NY; Shih SC
    BMC Infect Dis; 2016 Aug; 16(1):444. PubMed ID: 27553962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of efflux pump inhibitor in decreasing antibiotic cross-resistance of Pseudomonas aeruginosa in a burn hospital in Iran.
    Talebi-Taher M; Majidpour َ; Gholami A; Rasouli-Kouhi S; Adabi M
    J Infect Dev Ctries; 2016 Jun; 10(6):600-4. PubMed ID: 27367008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance to tobramycin and colistin in isolates of Pseudomonas aeruginosa from chronically colonized patients with cystic fibrosis under antimicrobial treatment.
    Valenza G; Radike K; Schoen C; Horn S; Oesterlein A; Frosch M; Abele-Horn M; Hebestreit H
    Scand J Infect Dis; 2010 Dec; 42(11-12):885-9. PubMed ID: 20735333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium induces tobramycin resistance in Pseudomonas aeruginosa by regulating RND efflux pumps.
    Khanam S; Guragain M; Lenaburg DL; Kubat R; Patrauchan MA
    Cell Calcium; 2017 Jan; 61():32-43. PubMed ID: 28034459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.